Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Results for the Year Ended December 31, 2024 Revenue reached RMB1,986.7 million Gross profit amounted to RMB687.4 million Net profit recorded RMB222.0 ...

Alto Pharmacy, a digital pharmaceutical startup based in San Francisco that’s backed by SoftBank Group Corp., agreed to be ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Perspective Therapeutics (CATX – Research ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Stock market benchmark indices rebounded on Thursday (March 27) after falling sharply in the previous session as continuous ...

Imagine standing on a vast, dark plain. Without light, you cannot see dips and rolls in the grass or make out hills and ...

PSU Banks, on the other hand, outperformed others, as the Nifty PSU Bank index settled with gains of 2.50 per cent, led by ...

Elon Musk's X is on pace for its first year of advertising revenue growth since the billionaire acquired the company in 2022, ...

Elon Musk-owned social media platform X is poised for the company's first year of advertising revenue growth since its ...

An exclusive interview with Pfizer’s Wayne Simmons on reshaping customer experience by listening to those interacting with ...

A new kind of pharma-telehealth partnership has come under scrutiny over concerns that such an arrangement could lead to inappropriate prescriptions and poor care.